AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2013
Dec 6, 2013
30786_dirs_2013-12-06_d0ca94a3-181f-49cb-8799-7c433a3e6a76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2013-12-05
Reporting Person: GOETZ JOHN (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-05 | Bio-Rad A Common Stock | M | 8000 | $53.75 | Acquired | 52396.9995 | Direct |
| 2013-12-05 | Bio-Rad A Common Stock | F | 5220 | $121.58 | Disposed | 47176.9995 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-12-05 | Non-Qualified Stock Option (right to buy) | $53.75 | M | 8000 | Disposed | 2014-02-04 | Bio-Rad A Common Stock (8000) | Direct |
Footnotes
F1: The option vested in five equal annual installments beginning on February 4, 2005.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13